ClinicalTrials.gov
public full text
Public Domain
Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
This trial designed to evaluate the toxicity and efficacy of tocilizumab in the treatment of steroid refractory acute graft versus host disease (GVHD).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)#1047956
- Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease#1338131
- COVID-19: Salvage TOcilizumab as a Rescue Measure#1088289
- TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients#1072407
- Cell Therapy for Immunomodulation in Kidney Transplantation#1350719
Record · ID 1214312
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive